Non-coding RNAs in gastric cancer

Gene

Volumn 560, Issue 1, 2015, Pages 1-8

  Wang, Jun ^a   Song, Yong Xi ^a   Wang, Zhen Ning ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer; Long non coding RNA; MicroRNA; Non coding RNA; Small interfering RNA

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; LONG UNTRANSLATED RNA; MICRORNA; MICRORNA 106A; MICRORNA 31; PIWI INTERACTING RNA; RNA INDUCED SILENCING COMPLEX; SMALL NUCLEOLAR RNA; SMALL UNTRANSLATED RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; UNTRANSLATED RNA; H19 LONG NON-CODING RNA; HOTAIR LONG UNTRANSLATED RNA, HUMAN;

APOPTOSIS; CANCER CELL; CANCER RESISTANCE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; DOWN REGULATION; DRUG TARGETING; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENOME IMPRINTING; HUMAN; LYMPH NODE METASTASIS; METASTASIS; NONHUMAN; ONCOGENE C MYC; PHENOTYPE; PRIORITY JOURNAL; REVIEW; STOMACH CANCER; STOMACH CARCINOGENESIS; TUMOR SUPPRESSOR GENE; UPREGULATION; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; PHYSIOLOGY; STOMACH TUMOR;

ANIMALS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; RNA, LONG NONCODING; RNA, SMALL NUCLEOLAR; RNA, SMALL UNTRANSLATED; RNA, UNTRANSLATED; STOMACH NEOPLASMS;

EID: 84923078133     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.02.004     Document Type: Review

References (115)

1. Alexander R.P., Fang G., Rozowsky J., Snyder M., Gerstein M.B. Annotating non-coding regions of the genome. Nat. Rev. Genet. 2010, 11:559-571.
2. Aravin A., Gaidatzis D., Pfeffer S., Lagos-Quintana M., Landgraf P., Iovino N., Morris P., Brownstein M.J., Kuramochi-Miyagawa S., Nakano T., Chien M., Russo J.J., Ju J., Sheridan R., Sander C., Zavolan M., Tuschl T. A novel class of small RNAs bind to MILI protein in mouse testes. Nature 2006, 442:203-207.
3. Arita T., Ichikawa D., Konishi H., Komatsu S., Shiozaki A., Shoda K., Kawaguchi T., Hirajima S., Nagata H., Kubota T., Fujiwara H., Okamoto K., Otsuji E. Circulating long non-coding RNAs in plasma of patients with gastric cancer. Anticancer Res. 2013, 33:3185-3193.
4. Bachellerie J.P., Cavaille J., Huttenhofer A. The expanding snoRNA world. Biochimie 2002, 84:775-790.
5. Bang Y.J., Van Cutsem E., Feyereislova A., Chung H.C., Shen L., Sawaki A., Lordick F., Ohtsu A., Omuro Y., Satoh T., Aprile G., Kulikov E., Hill J., Lehle M., Ruschoff J., Kang Y.K., To G.A.T.I. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 2010, 376:687-697.
6. Bortolin M.L., Kiss T. Human U19 intron-encoded snoRNA is processed from a long primary transcript that possesses little potential for protein coding. RNA 1998, 4:445-454.
7. Brosnan C.A., Voinnet O. The long and the short of noncoding RNAs. Curr. Opin. Cell Biol. 2009, 21:416-425.
8. Cai X., Cullen B.R. The imprinted H19 noncoding RNA is a primary microRNA precursor. RNA 2007, 13:313-316.
9. Cai X., Hagedorn C.H., Cullen B.R. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 2004, 10:1957-1966.
10. Cai L., Ma X., Huang Y., Zou Y., Chen X. Aberrant histone methylation and the effect of Suv39H1 siRNA on gastric carcinoma. Oncol. Rep. 2014, 31:2593-2600.
11. Caley D.P., Pink R.C., Trujillano D., Carter D.R. Long noncoding RNAs, chromatin, and development. ScientificWorldJournal 2010, 10:90-102.
12. Calore F., Lovat F., Garofalo M. Non-coding RNAs and cancer. Int. J. Mol. Sci. 2013, 14:17085-17110.
13. Cao W.J., Wu H.L., He B.S., Zhang Y.S., Zhang Z.Y. Analysis of long non-coding RNA expression profiles in gastric cancer. World J. Gastroenterol. 2013, 19:3658-3664.
14. Cao K., Xie D., Cao P., Zou Q., Lu C., Xiao S., Zhou J., Peng X. SiRNA-mediated flotillin-2 (Flot2) downregulation inhibits cell proliferation, migration, and invasion in gastric carcinoma cells. Oncol. Res. 2014, 21:271-279.
15. Carthew R.W., Sontheimer E.J. Origins and mechanisms of miRNAs and siRNAs. Cell 2009, 136:642-655.
16. Chendrimada T.P., Gregory R.I., Kumaraswamy E., Norman J., Cooch N., Nishikura K., Shiekhattar R. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 2005, 436:740-744.
17. Cheng J., Guo J.M., Xiao B.X., Miao Y., Jiang Z., Zhou H., Li Q.N. piRNA, the new non-coding RNA, is aberrantly expressed in human cancer cells. Clin. Chim. Acta 2011, 412:1621-1625.
18. Cheng J., Deng H., Xiao B., Zhou H., Zhou F., Shen Z., Guo J. piR-823, a novel non-coding small RNA, demonstrates in vitro and in vivo tumor suppressive activity in human gastric cancer cells. Cancer Lett. 2012, 315:12-17.
19. Cui L., Lou Y., Zhang X., Zhou H., Deng H., Song H., Yu X., Xiao B., Wang W., Guo J. Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using piRNAs as markers. Clin. Biochem. 2011, 44:1050-1057.
20. Deng M., Jing D.D., Meng X.J. Effect of MUC1 siRNA on drug resistance of gastric cancer cells to trastuzumab. Asian Pac. J. Cancer Prev. 2013, 14:127-131.
21. Denli A.M., Tops B.B., Plasterk R.H., Ketting R.F., Hannon G.J. Processing of primary microRNAs by the Microprocessor complex. Nature 2004, 432:231-235.
22. Derrien T., Johnson R., Bussotti G., Tanzer A., Djebali S., Tilgner H., Guernec G., Martin D., Merkel A., Knowles D.G., Lagarde J., Veeravalli L., Ruan X., Ruan Y., Lassmann T., Carninci P., Brown J.B., Lipovich L., Gonzalez J.M., Thomas M., Davis C.A., Shiekhattar R., Gingeras T.R., Hubbard T.J., Notredame C., Harrow J., Guigo R. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012, 22:1775-1789.
23. Dinger M.E., Gascoigne D.K., Mattick J.S. The evolution of RNAs with multiple functions. Biochimie 2011, 93:2013-2018.
24. Dong X.Y., Rodriguez C., Guo P., Sun X., Talbot J.T., Zhou W., Petros J., Li Q., Vessella R.L., Kibel A.S., Stevens V.L., Calle E.E., Dong J.T. SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer. Hum. Mol. Genet. 2008, 17:1031-1042.
25. Dong X.Y., Guo P., Boyd J., Sun X., Li Q., Zhou W., Dong J.T. Implication of snoRNA U50 in human breast cancer. J. Genet. Genomics 2009, 36:447-454.
26. Dugimont T., Montpellier C., Adriaenssens E., Lottin S., Dumont L., Iotsova V., Lagrou C., Stehelin D., Coll J., Curgy J.J. The H19 TATA-less promoter is efficiently repressed by wild-type tumor suppressor gene product p53. Oncogene 1998, 16:2395-2401.
27. Endo H., Shiroki T., Nakagawa T., Yokoyama M., Tamai K., Yamanami H., Fujiya T., Sato I., Yamaguchi K., Tanaka N., Iijima K., Shimosegawa T., Sugamura K., Satoh K. Enhanced expression of long non-coding RNA HOTAIR is associated with the development of gastric cancer. PLoS ONE 2013, 8:e77070.
28. Flores O., Kennedy E.M., Skalsky R.L., Cullen B.R. Differential RISC association of endogenous human microRNAs predicts their inhibitory potential. Nucleic Acids Res. 2014, 42:4629-4639.
29. Gardner P.P., Bateman A., Poole A.M. SnoPatrol: how many snoRNA genes are there?. J. Biol. 2010, 9:4.
30. Girard A., Sachidanandam R., Hannon G.J., Carmell M.A. A germline-specific class of small RNAs binds mammalian Piwi proteins. Nature 2006, 442:199-202.
31. Gregory R.I., Yan K.P., Amuthan G., Chendrimada T., Doratotaj B., Cooch N., Shiekhattar R. The Microprocessor complex mediates the genesis of microRNAs. Nature 2004, 432:235-240.
32. Gregory R.I., Chendrimada T.P., Cooch N., Shiekhattar R. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 2005, 123:631-640.
33. Grivna S.T., Beyret E., Wang Z., Lin H. A novel class of small RNAs in mouse spermatogenic cells. Genes Dev. 2006, 20:1709-1714.
34. Gupta R.A., Shah N., Wang K.C., Kim J., Horlings H.M., Wong D.J., Tsai M.C., Hung T., Argani P., Rinn J.L., Wang Y., Brzoska P., Kong B., Li R., West R.B., van de Vijver M.J., Sukumar S., Chang H.Y. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010, 464:1071-1076.
35. Hajjari M., Behmanesh M., Sadeghizadeh M., Zeinoddini M. Up-regulation of HOTAIR long non-coding RNA in human gastric adenocarcinoma tissues. Med. Oncol. 2013, 30:670.
36. Hao Y., Crenshaw T., Moulton T., Newcomb E., Tycko B. Tumour-suppressor activity of H19 RNA. Nature 1993, 365:764-767.
37. Huang T., Alvarez A., Hu B., Cheng S.Y. Noncoding RNAs in cancer and cancer stem cells. Chin. J. Cancer 2013, 32:582-593.
38. Jia H., Zhang Z., Zou D., Wang B., Yan Y., Luo M., Dong L., Yin H., Gong B., Li Z., Wang F., Song W., Liu C., Ma Y., Zhang J., Zhao H., Li J., Yu J. MicroRNA-10a is down-regulated by DNA methylation and functions as a tumor suppressor in gastric cancer cells. PLoS ONE 2014, 9:e88057.
39. John B., Enright A.J., Aravin A., Tuschl T., Sander C., Marks D.S. Human microRNA targets. PLoS Biol. 2004, 2:e363.
40. Kapranov P., Drenkow J., Cheng J., Long J., Helt G., Dike S., Gingeras T.R. Examples of the complex architecture of the human transcriptome revealed by RACE and high-density tiling arrays. Genome Res. 2005, 15:987-997.
41. Kapranov P., Cheng J., Dike S., Nix D.A., Duttagupta R., Willingham A.T., Stadler P.F., Hertel J., Hackermuller J., Hofacker I.L., Bell I., Cheung E., Drenkow J., Dumais E., Patel S., Helt G., Ganesh M., Ghosh S., Piccolboni A., Sementchenko V., Tammana H., Gingeras T.R. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 2007, 316:1484-1488.
42. Kim K., Jutooru I., Chadalapaka G., Johnson G., Frank J., Burghardt R., Kim S., Safe S. HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene 2013, 32:1616-1625.
43. Kiss A.M., Jady B.E., Bertrand E., Kiss T. Human box H/ACA pseudouridylation guide RNA machinery. Mol. Cell. Biol. 2004, 24:5797-5807.
44. Kogo R., Shimamura T., Mimori K., Kawahara K., Imoto S., Sudo T., Tanaka F., Shibata K., Suzuki A., Komune S., Miyano S., Mori M. Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res. 2011, 71:6320-6326.
45. Kupcinskas J., Wex T., Link A., Leja M., Bruzaite I., Steponaitiene R., Juzenas S., Gyvyte U., Ivanauskas A., Ancans G., Petrenkiene V., Skieceviciene J., Kupcinskas L., Malfertheiner P. Gene polymorphisms of microRNAs in Helicobacter pylori-induced high risk atrophic gastritis and gastric cancer. PLoS ONE 2014, 9:e87467.
46. Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J., Devon K., Dewar K., Doyle M., FitzHugh W., Funke R., Gage D., Harris K., Heaford A., Howland J., Kann L., Lehoczky J., LeVine R., McEwan P., McKernan K., Meldrim J., Mesirov J.P., Miranda C., Morris W., Naylor J., Raymond C., Rosetti M., Santos R., Sheridan A., Sougnez C., Stange-Thomann N., Stojanovic N., Subramanian A., Wyman D., Rogers J., Sulston J., Ainscough R., Beck S., Bentley D., Burton J., Clee C., Carter N., Coulson A., Deadman R., Deloukas P., Dunham A., Dunham I., Durbin R., French L., Grafham D., Gregory S., Hubbard T., Humphray S., Hunt A., Jones M., Lloyd C., McMurray A., Matthews L., Mercer S., Milne S., Mullikin J.C., Mungall A., Plumb R., Ross M., Shownkeen R., Sims S., Waterston R.H., Wilson R.K., Hillier L.W., McPherson J.D., Marra M.A., Mardis E.R., Fulton L.A., Chinwalla A.T., Pepin K.H., Gish W.R., Chissoe S.L., Wendl M.C., Delehaunty K.D., Miner T.L., Delehaunty A., Kramer J.B., Cook L.L., Fulton R.S., Johnson D.L., Minx P.J., Clifton S.W., Hawkins T., Branscomb E., Predki P., Richardson P., Wenning S., Slezak T., Doggett N., Cheng J.F., Olsen A., Lucas S., Elkin C., Uberbacher E., Frazier M., et al. Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921.
47. Law P.T., Qin H., Ching A.K., Lai K.P., Co N.N., He M., Lung R.W., Chan A.W., Chan T.F., Wong N. Deep sequencing of small RNA transcriptome reveals novel non-coding RNAs in hepatocellular carcinoma. J. Hepatol. 2013, 58:1165-1173.
48. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
49. Lee Y., Jeon K., Lee J.T., Kim S., Kim V.N. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J. 2002, 21:4663-4670.
50. Lee Y., Ahn C., Han J., Choi H., Kim J., Yim J., Lee J., Provost P., Radmark O., Kim S., Kim V.N. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003, 425:415-419.
51. Lee Y., Kim M., Han J., Yeom K.H., Lee S., Baek S.H., Kim V.N. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 2004, 23:4051-4060.
52. Lee J.H., Schutte D., Wulf G., Fuzesi L., Radzun H.J., Schweyer S., Engel W., Nayernia K. Stem-cell protein Piwil2 is widely expressed in tumors and inhibits apoptosis through activation of Stat3/Bcl-XL pathway. Hum. Mol. Genet. 2006, 15:201-211.
53. Lee Y., Hur I., Park S.Y., Kim Y.K., Suh M.R., Kim V.N. The role of PACT in the RNA silencing pathway. EMBO J. 2006, 25:522-532.
54. Liao Q., Liu C., Yuan X., Kang S., Miao R., Xiao H., Zhao G., Luo H., Bu D., Zhao H., Skogerbo G., Wu Z., Zhao Y. Large-scale prediction of long non-coding RNA functions in a coding-non-coding gene co-expression network. Nucleic Acids Res. 2011, 39:3864-3878.
55. Liu H.T., Lu C.L. Effect of silencing Bcl-2 expression by small interfering RNA on radiosensitivity of gastric cancer BGC823 cells. Asian Pac. J. Trop. Med. 2013, 6:49-52.
56. Liu X., Sun Y., Guo J., Ma H., Li J., Dong B., Jin G., Zhang J., Wu J., Meng L., Shou C. Expression of hiwi gene in human gastric cancer was associated with proliferation of cancer cells. Int. J. Cancer 2006, 118:1922-1929.
57. Liu R., Zhang C., Hu Z., Li G., Wang C., Yang C., Huang D., Chen X., Zhang H., Zhuang R., Deng T., Liu H., Yin J., Wang S., Zen K., Ba Y., Zhang C.Y. A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur. J. Cancer 2011, 47:784-791.
58. Liu K., Chen H., You Q., Shi H., Wang Z. The siRNA cocktail targeting VEGF and HER2 inhibition on the proliferation and induced apoptosis of gastric cancer cell. Mol. Cell. Biochem. 2014, 386:117-124.
59. Liu X.H., Sun M., Nie F.Q., Ge Y.B., Zhang E.B., Yin D.D., Kong R., Xia R., Lu K.H., Li J.H., De W., Wang K.M., Wang Z.X. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Mol. Cancer 2014, 13:92.
60. Liu W.J., Xu Q., Sun L.P., Dong Q.G., He C.Y., Yuan Y. Expression of serum let-7c, let-7i, and let-7f microRNA with its target gene, pepsinogen C, in gastric cancer and precancerous disease. Tumour Biol. 2014, (Dec 31. [Epub ahead of print]). 10.1007/s13277-014-2967-9.
61. Long N., Moore M.A., Chen W., Gao C.M., Lai M.S., Mizoue T., Oyunchimeg D., Park S., Shin H.R., Tajima K., Yoo K.Y., Sobue T. Cancer epidemiology and control in north-East Asia - past, present and future. Asian Pac. J. Cancer Prev. 2010, 11(Suppl. 2):107-148.
62. Lu Y., Zhang K., Li C., Yao Y., Tao D., Liu Y., Zhang S., Ma Y. Piwil2 suppresses p53 by inducing phosphorylation of signal transducer and activator of transcription 3 in tumor cells. PLoS ONE 2012, 7:e30999.
63. Ma G.J., Gu R.M., Zhu M., Wen X., Li J.T., Zhang Y.Y., Zhang X.M., Chen S.Q. Plasma post-operative miR-21 expression in the prognosis of gastric cancers. Asian Pac. J. Cancer Prev. 2013, 14:7551-7554.
64. Mannoor K., Liao J., Jiang F. Small nucleolar RNAs in cancer. Biochim. Biophys. Acta 2012, 1826:121-128.
65. Matouk I.J., DeGroot N., Mezan S., Ayesh S., Abu-lail R., Hochberg A., Galun E. The H19 non-coding RNA is essential for human tumor growth. PLoS ONE 2007, 2:e845.
66. Matouk I.J., Mezan S., Mizrahi A., Ohana P., Abu-Lail R., Fellig Y., Degroot N., Galun E., Hochberg A. The oncofetal H19 RNA connection: hypoxia, p53 and cancer. Biochim. Biophys. Acta 2010, 1803:443-451.
67. Mei D., Song H., Wang K., Lou Y., Sun W., Liu Z., Ding X., Guo J. Up-regulation of SUMO1 pseudogene 3 (SUMO1P3) in gastric cancer and its clinical association. Med. Oncol. 2013, 30:709.
68. Mercer T.R., Dinger M.E., Mattick J.S. Long non-coding RNAs: insights into functions. Nat. Rev. Genet. 2009, 10:155-159.
69. Mourtada-Maarabouni M., Hedge V.L., Kirkham L., Farzaneh F., Williams G.T. Growth arrest in human T-cells is controlled by the non-coding RNA growth-arrest-specific transcript 5 (GAS5). J. Cell Sci. 2008, 121:939-946.
70. Mourtada-Maarabouni M., Pickard M.R., Hedge V.L., Farzaneh F., Williams G.T. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene 2009, 28:195-208.
71. Niinuma T., Suzuki H., Nojima M., Nosho K., Yamamoto H., Takamaru H., Yamamoto E., Maruyama R., Nobuoka T., Miyazaki Y., Nishida T., Bamba T., Kanda T., Ajioka Y., Taguchi T., Okahara S., Takahashi H., Nishida Y., Hosokawa M., Hasegawa T., Tokino T., Hirata K., Imai K., Toyota M., Shinomura Y. Upregulation of miR-196a and HOTAIR drive malignant character in gastrointestinal stromal tumors. Cancer Res. 2012, 72:1126-1136.
72. Numata K., Kanai A., Saito R., Kondo S., Adachi J., Wilming L.G., Hume D.A., Hayashizaki Y., Tomita M., Group R.G., Members G.S.L. Identification of putative noncoding RNAs among the RIKEN mouse full-length cDNA collection. Genome Res. 2003, 13:1301-1306.
73. Pang K.C., Dinger M.E., Mercer T.R., Malquori L., Grimmond S.M., Chen W., Mattick J.S. Genome-wide identification of long noncoding RNAs in CD8+ T cells. J. Immunol. 2009, 182:7738-7748.
74. Pang Q., Ge J., Shao Y., Sun W., Song H., Xia T., Xiao B., Guo J. Increased expression of long intergenic non-coding RNA LINC00152 in gastric cancer and its clinical significance. Tumour Biol. 2014, 35:5441-5447.
75. Park S.M., Park S.J., Kim H.J., Kwon O.H., Kang T.W., Sohn H.A., Kim S.K., Moo Noh S., Song K.S., Jang S.J., Sung Kim Y., Kim S.Y. A known expressed sequence tag, BM742401, is a potent lincRNA inhibiting cancer metastasis. Exp. Mol. Med. 2013, 45:e31.
76. Perez D.S., Hoage T.R., Pritchett J.R., Ducharme-Smith A.L., Halling M.L., Ganapathiraju S.C., Streng P.S., Smith D.I. Long, abundantly expressed non-coding transcripts are altered in cancer. Hum. Mol. Genet. 2008, 17:642-655.
77. Ponting C.P., Oliver P.L., Reik W. Evolution and functions of long noncoding RNAs. Cell 2009, 136:629-641.
78. Qiao D., Zeeman A.M., Deng W., Looijenga L.H., Lin H. Molecular characterization of hiwi, a human member of the piwi gene family whose overexpression is correlated to seminomas. Oncogene 2002, 21:3988-3999.
79. Rinn J.L., Chang H.Y. Genome regulation by long noncoding RNAs. Annu. Rev. Biochem. 2012, 81:145-166.
80. Rinn J.L., Kertesz M., Wang J.K., Squazzo S.L., Xu X., Brugmann S.A., Goodnough L.H., Helms J.A., Farnham P.J., Segal E., Chang H.Y. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007, 129:1311-1323.
81. Sadio A., Gustafsson J.K., Pereira B., Gomes C.P., Hansson G.C., David L., Pego A.P., Almeida R. Modified-chitosan/siRNA nanoparticles downregulate cellular CDX2 expression and cross the gastric mucus barrier. PLoS ONE 2014, 9:e99449.
82. Sasaki T., Shiohama A., Minoshima S., Shimizu N. Identification of eight members of the Argonaute family in the human genome. Genomics 2003, 82:323-330.
83. Sempere L.F., Freemantle S., Pitha-Rowe I., Moss E., Dmitrovsky E., Ambros V. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol. 2004, 5:R13.
84. Shin H.R., Carlos M.C., Varghese C. Cancer control in the Asia Pacific region: current status and concerns. Jpn. J. Clin. Oncol. 2012, 42:867-881.
85. Shin J.Y., Kim Y.I., Cho S.J., Lee M.K., Kook M.C., Lee J.H., Lee S.S., Ashktorab H., Smoot D.T., Ryu K.W., Kim Y.W., Choi I.J. MicroRNA 135a suppresses lymph node metastasis through down-regulation of ROCK1 in early gastric cancer. PLoS ONE 2014, 9:e85205.
86. Smith C.M., Steitz J.A. Sno storm in the nucleolus: new roles for myriad small RNPs. Cell 1997, 89:669-672.
87. Song H., Sun W., Ye G., Ding X., Liu Z., Zhang S., Xia T., Xiao B., Xi Y., Guo J. Long non-coding RNA expression profile in human gastric cancer and its clinical significances. J. Transl. Med. 2013, 11:225.
88. Song J., Bai Z., Zhang Z. MicroRNAs are implicated in the initiation and progression of gastric cancer. Chin. Med. J. (Engl.) 2014, 127:554-559.
89. Sun W., Wu Y., Yu X., Liu Y., Song H., Xia T., Xiao B., Guo J. Decreased expression of long noncoding RNA AC096655.1-002 in gastric cancer and its clinical significance. Tumour Biol. 2013, 34:2697-2701.
90. Sun M., Xia R., Jin F., Xu T., Liu Z., De W., Liu X. Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer. Tumour Biol. 2014, 35:1065-1073.
91. Tang J.Y., Lee J.C., Chang Y.T., Hou M.F., Huang H.W., Liaw C.C., Chang H.W. Long noncoding RNAs-related diseases, cancers, and drugs. ScientificWorldJournal 2013, 2013:943539.
92. Taubert H., Greither T., Kaushal D., Wurl P., Bache M., Bartel F., Kehlen A., Lautenschlager C., Harris L., Kraemer K., Meye A., Kappler M., Schmidt H., Holzhausen H.J., Hauptmann S. Expression of the stem cell self-renewal gene Hiwi and risk of tumour-related death in patients with soft-tissue sarcoma. Oncogene 2007, 26:1098-1100.
93. Thorvaldsen J.L., Duran K.L., Bartolomei M.S. Deletion of the H19 differentially methylated domain results in loss of imprinted expression of H19 and Igf2. Genes Dev. 1998, 12:3693-3702.
94. Tsai M.C., Spitale R.C., Chang H.Y. Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res. 2011, 71:3-7.
95. Vella M.C., Choi E.Y., Lin S.Y., Reinert K., Slack F.J. The C. elegans microRNA let-7 binds to imperfect let-7 complementary sites from the lin-41 3'UTR. Genes Dev. 2004, 18:132-137.
96. Wang Y., Liu Y., Shen X., Zhang X., Chen X., Yang C., Gao H. The PIWI protein acts as a predictive marker for human gastric cancer. Int. J. Clin. Exp. Pathol. 2012, 5:315-325.
97. Wang Z., Wang J., Yang Y., Hao B., Wang R., Li Y., Wu Q. Loss of has-miR-337-3p expression is associated with lymph node metastasis of human gastric cancer. J. Exp. Clin. Cancer Res. 2013, 32:76.
98. Wang Y., Feng X., Jia R., Liu G., Zhang M., Fan D., Gao S. Microarray expression profile analysis of long non-coding RNAs of advanced stage human gastric cardia adenocarcinoma. Mol. Genet. Genomics 2014, 289:291-302.
99. Woo C.J., Kingston R.E. HOTAIR lifts noncoding RNAs to new levels. Cell 2007, 129:1257-1259.
100. Wu H.H., Lin W.C., Tsai K.W. Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers. Expert Rev. Mol. Med. 2014, 16:e1.
101. Xia J.T., Chen L.Z., Jian W.H., Wang K.B., Yang Y.Z., He W.L., He Y.L., Chen D., Li W. MicroRNA-362 induces cell proliferation and apoptosis resistance in gastric cancer by activation of NF-kappaB signaling. J. Transl. Med. 2014, 12:33.
102. Xiao B., Guo J. Long noncoding RNA AC096655.1-002 has been officially named as gastric cancer-associated transcript 1, GACAT1. Tumour Biol. 2013, 34:3271.
103. Xiao B., Guo J., Miao Y., Jiang Z., Huan R., Zhang Y., Li D., Zhong J. Detection of miR-106a in gastric carcinoma and its clinical significance. Clin. Chim. Acta 2009, 400:97-102.
104. Xu Z.Y., Yu Q.M., Du Y.A., Yang L.T., Dong R.Z., Huang L., Yu P.F., Cheng X.D. Knockdown of long non-coding RNA HOTAIR suppresses tumor invasion and reverses epithelial-mesenchymal transition in gastric cancer. Int. J. Biol. Sci. 2013, 9:587-597.
105. Yang F., Bi J., Xue X., Zheng L., Zhi K., Hua J., Fang G. Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells. FEBS J. 2012, 279:3159-3165.
106. Yang F., Xue X., Bi J., Zheng L., Zhi K., Gu Y., Fang G. Long noncoding RNA CCAT1, which could be activated by c-Myc, promotes the progression of gastric carcinoma. J. Cancer Res. Clin. Oncol. 2013, 139:437-445.
107. Yang F., Xue X., Zheng L., Bi J., Zhou Y., Zhi K., Gu Y., Fang G. Long non-coding RNA GHET1 promotes gastric carcinoma cell proliferation by increasing c-Myc mRNA stability. FEBS J. 2014, 281:802-813.
108. Yi R., Qin Y., Macara I.G., Cullen B.R. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 2003, 17:3011-3016.
109. Zhang Y., Guo J., Li D., Xiao B., Miao Y., Jiang Z., Zhuo H. Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance. Med. Oncol. 2010, 27:685-689.
110. Zhang E.B., Han L., Yin D.D., Kong R., De W., Chen J. c-Myc-induced, long, noncoding H19 affects cell proliferation and predicts a poor prognosis in patients with gastric cancer. Med. Oncol. 2014, 31:914.
111. Zhao Y., Guo Q., Chen J., Hu J., Wang S., Sun Y. Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and in vitro investigation. Oncol. Rep. 2014, 31:358-364.
112. Zhao Y., Huang J., Zhang L., Qu Y., Li J., Yu B., Yan M., Yu Y., Liu B., Zhu Z. MiR-133b is frequently decreased in gastric cancer and its overexpression reduces the metastatic potential of gastric cancer cells. BMC Cancer 2014, 14:34.
113. Zhou C., Li X., Zhang X., Liu X., Tan Z., Yang C., Zhang J. MicroRNA-372 maintains oncogene characteristics by targeting TNFAIP1 and affects NFkappaB signaling in human gastric carcinoma cells. Int. J. Oncol. 2013, 42:635-642.
114. Zhuang H., Ma X., Lai Y., Xu X., Wang X. Effect of siRNA targeting HDAC1 gene on proliferation, apoptosis, histone acetylation, and histone methylation in gastric cancer cells in vitro. Nan Fang Yi Ke Da Xue Xue Bao 2014, 34:246-250.
115. Zhuang M., Gao W., Xu J., Wang P., Shu Y. The long non-coding RNA H19-derived miR-675 modulates human gastric cancer cell proliferation by targeting tumor suppressor RUNX1. Biochem. Biophys. Res. Commun. 2014, 448:315-322.